Treatment of Diabetes Insipidus
Treatment differs fundamentally between central and nephrogenic diabetes insipidus: desmopressin (synthetic vasopressin) is the definitive treatment for central DI, while nephrogenic DI requires thiazide diuretics, prostaglandin synthesis inhibitors, and dietary modifications since these patients cannot respond to vasopressin. 1
Central Diabetes Insipidus Treatment
For central DI, desmopressin is the primary treatment as it replaces the deficient arginine vasopressin (AVP). This directly addresses the underlying pathophysiology of inadequate hormone production 2, 3.
Key Management Points:
- Ensure free access to water at all times to prevent hypernatremic dehydration 1
- Titrate desmopressin dose to control polyuria while avoiding hyponatremia
- Monitor serum sodium, osmolality, and urine output regularly
- Patients must carry emergency identification and management plans 1
Nephrogenic Diabetes Insipidus Treatment
Nephrogenic DI is more complex because the kidneys cannot respond to vasopressin, making desmopressin ineffective. The 2025 international expert consensus provides the most current treatment algorithm 1:
First-Line Approach: Dietary Modifications
- Low-salt diet (≤6 g/day) to reduce renal osmotic load 1
- Low-protein diet (<1 g/kg/day) to minimize urine solute excretion 1
- Mandatory dietetic counseling from experienced dietitians 1
- In infants: normal-for-age milk intake (not just water) to ensure adequate calories 1
Pharmacological Treatment
For symptomatic infants and children, start combination therapy with thiazide diuretics plus prostaglandin synthesis inhibitors 1:
Thiazide Diuretics
- Can reduce urine output by up to 50% initially through volume depletion 1
- Induce mild hypovolemia, increasing proximal tubular sodium and water reabsorption 4
- Add amiloride if thiazides cause hypokalaemia 1
- Long-term effects are more modest than initial response 1
Prostaglandin Synthesis Inhibitors (NSAIDs)
- Used in combination with thiazides in symptomatic patients 1
- Must be discontinued in adulthood or when continence is achieved 1
- Absolutely contraindicated in pregnancy 1
Treatment Decisions Based on Patient Preference
The continuation or discontinuation of diuretics should be guided by patient preference, balancing efficacy against side effects 1. Many patients discontinue medications with increasing age as they develop better coping mechanisms 1.
Special Considerations for Infants
- Consider tube feeding (nasogastric or gastrostomy) if repeated vomiting, dehydration, or failure to thrive occur 1
- 20-30% of children with NDI require tube feeding at some point, typically discontinued by age 4 1
- Space oral feeds carefully to reduce gastroesophageal reflux from large fluid volumes 1
Emergency Management
All patients must have an emergency plan and medical alert identification 1. Critical emergency principles include:
- Use 5% dextrose in water for IV rehydration (not normal saline) 1
- Calculate fluid administration to avoid decreasing serum sodium faster than 8 mmol/L/day 1
- Monitor neurological status, fluid balance, weight, and electrolytes closely 1
- Treat in specialized centers or under expert consultation 1
Common Pitfall
When patients with NDI are hospitalized for unrelated conditions, medical staff often fail to appreciate their massive fluid requirements. Close liaison with a specialist center is essential to prevent life-threatening hypernatremia 1.
Monitoring and Follow-Up
Patients require multidisciplinary care including nephrologist, dietitian, psychologist, social worker, and urologist 1:
- Monitor height, weight, serum sodium, potassium, creatinine, and osmolality at each visit 1
- Kidney ultrasound every 2 years to detect urinary tract dilatation from chronic polyuria 1
- Assess for nocturnal enuresis (full continence typically not achieved until second decade) 1
- Evaluate treatment efficacy via urine osmolality, urine output, and growth parameters 1
Quality of Life Considerations
The goal is reducing urine output while maintaining fluid balance, normonatremia, and acceptable quality of life 5. Patients should have maximum control over their fluid intake 1. Treatment decisions must balance symptom control against medication side effects and patient preferences, particularly as children mature into adults who can better self-manage their condition.